321 related articles for article (PubMed ID: 11305380)
1. Methotrexate in psoriasis: 26 years' experience with low-dose long-term treatment.
Haustein UF; Rytter M
J Eur Acad Dermatol Venereol; 2000 Sep; 14(5):382-8. PubMed ID: 11305380
[TBL] [Abstract][Full Text] [Related]
2. Methotrexate revisited: effects of long-term treatment in psoriasis.
Van Dooren-Greebe RJ; Kuijpers AL; Mulder J; De Boo T; Van de Kerkhof PC
Br J Dermatol; 1994 Feb; 130(2):204-10. PubMed ID: 8123573
[TBL] [Abstract][Full Text] [Related]
3. Short-term methotrexate therapy in psoriasis: a study of 197 patients.
Kumar B; Saraswat A; Kaur I
Int J Dermatol; 2002 Jul; 41(7):444-8. PubMed ID: 12121564
[TBL] [Abstract][Full Text] [Related]
4. [Long-term follow-up of the efficacy of methotrexate alone or in combination with low doses of oral corticosteroids in the treatment of alopecia areata totalis or universalis].
Chartaux E; Joly P
Ann Dermatol Venereol; 2010; 137(8-9):507-13. PubMed ID: 20804893
[TBL] [Abstract][Full Text] [Related]
5. Pneumonitis complicating methotrexate therapy for pustular psoriasis.
Ameen M; Taylor DA; Williams IP; Wells AU; Barkert JN
J Eur Acad Dermatol Venereol; 2001 May; 15(3):247-9. PubMed ID: 11683290
[TBL] [Abstract][Full Text] [Related]
6. The efficacy of methotrexate in psoriasis--a review of 40 cases.
Collins P; Rogers S
Clin Exp Dermatol; 1992 Jul; 17(4):257-60. PubMed ID: 1451315
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.
Tournier A; Khemis A; Maccari F; Reguiai Z; Bégon E; Fougerousse AC; Amy de la Breteque M; Beneton N; Parier J; Boyé T; Avenel-Audran M; Girard C; Pallure V; Perrot JL; Bastien M; Mahé E; Beauchet A;
Ann Dermatol Venereol; 2019 Feb; 146(2):106-114. PubMed ID: 30704943
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis.
Prodanovich S; Ma F; Taylor JR; Pezon C; Fasihi T; Kirsner RS
J Am Acad Dermatol; 2005 Feb; 52(2):262-7. PubMed ID: 15692471
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate in childhood psoriasis.
Kumar B; Dhar S; Handa S; Kaur I
Pediatr Dermatol; 1994 Sep; 11(3):271-3. PubMed ID: 7971565
[TBL] [Abstract][Full Text] [Related]
11. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
Lindsay K; Fraser AD; Layton A; Goodfield M; Gruss H; Gough A
Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
[TBL] [Abstract][Full Text] [Related]
12. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
Amital H; Arnson Y; Chodick G; Shalev V
Rheumatology (Oxford); 2009 Sep; 48(9):1107-10. PubMed ID: 19578136
[TBL] [Abstract][Full Text] [Related]
13. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
Bronckers IMGJ; Seyger MMB; West DP; Lara-Corrales I; Tollefson M; Tom WL; Hogeling M; Belazarian L; Zachariae C; Mahé E; Siegfried E; Philipp S; Szalai Z; Vleugels RA; Holland K; Murphy R; Baselga E; Cordoro K; Lambert J; Alexopoulos A; Mrowietz U; Kievit W; Paller AS;
JAMA Dermatol; 2017 Nov; 153(11):1147-1157. PubMed ID: 28903160
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of systemic methotrexate in two fixed doses of 10 mg or 25 mg orally once weekly in adult patients with severe plaque-type psoriasis: a prospective, randomized, double-blind, dose-ranging study.
Dogra S; Krishna V; Kanwar AJ
Clin Exp Dermatol; 2012 Oct; 37(7):729-34. PubMed ID: 22830389
[TBL] [Abstract][Full Text] [Related]
15. Sequential liver biopsies during long-term methotrexate treatment for psoriasis: a reappraisal.
Boffa MJ; Chalmers RJ; Haboubi NY; Shomaf M; Mitchell DM
Br J Dermatol; 1995 Nov; 133(5):774-8. PubMed ID: 8555032
[TBL] [Abstract][Full Text] [Related]
16. Interruption of long-term methotrexate treatment in psoriasis. Evaluation of clinical course and laboratory parameters after discontinuation and reintroduction of weekly oral methotrexate.
van Dooren-Greebe RJ; Kuijpers AL; Termorshuizen F; van de Kerkhof PC
Acta Derm Venereol; 1995 Sep; 75(5):393-6. PubMed ID: 8615062
[TBL] [Abstract][Full Text] [Related]
17. Risk-benefit assessment of methotrexate in the treatment of severe psoriasis.
Kuijpers AL; van de Kerkhof PC
Am J Clin Dermatol; 2000; 1(1):27-39. PubMed ID: 11702302
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of liver fibrosis by transient elastography in methotrexate treated patients.
Barbero-Villares A; Mendoza J; Trapero-Marugan M; Gonzalez-Alvaro I; Daudén E; Gisbert JP; Moreno-Otero R
Med Clin (Barc); 2011 Nov; 137(14):637-9. PubMed ID: 21719043
[TBL] [Abstract][Full Text] [Related]
19. Toxicity of methotrexate treatment in psoriasis and psoriatic arthritis--short- and long-term toxicity in 104 patients.
Wollina U; Ständer K; Barta U
Clin Rheumatol; 2001; 20(6):406-10. PubMed ID: 11771523
[TBL] [Abstract][Full Text] [Related]
20. Systemic methotrexate treatment in childhood psoriasis: further experience in 24 children from India.
Kaur I; Dogra S; De D; Kanwar AJ
Pediatr Dermatol; 2008; 25(2):184-8. PubMed ID: 18429775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
